# Surmasis Pharmaceutical, LLC – FDA Inspection, Aug 1, 2025

Source: https://www.keypedia.com/records/fda_inspections/surmasis-pharmaceutical-llc/5fb29e39-e823-41b8-9d3c-db716adf874c
Source feed: FDA_Inspections

> FDA inspection 1277270 of Surmasis Pharmaceutical, LLC, August 01, 2025. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 211 and 820. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277270
- Company Name: Surmasis Pharmaceutical, LLC
- Inspection Date: 2025-08-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Kansas City District Office
- Citation Count: 4

## Related Documents

- FDA Inspection 1121169 - 2020-03-19
- [FDA Inspection 1042777 - 2018-03-01](https://www.keypedia.com/records/fda_inspections/surmasis-pharmaceutical-llc/e05262f6-17af-45f8-8849-59e1059d8573)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/aranjeet-singh/7359f43e-0e36-4cdd-a77d-3371d8b44b99)
- [FDA Associated Person](https://www.keypedia.com/people/cecilia-h-kieu/3ba5feb0-d49e-4301-ae5c-b84bd604a159)
- [FDA Associated Person](https://www.keypedia.com/people/katherine-e-jacobitz/9a713b44-95c4-43a2-83bb-8d30062d8345)

Company: https://www.keypedia.com/companies/surmasis-pharmaceutical-llc/6f9dfe3c-c8c3-4740-b9a8-0ecc1bb9b400

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79